The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma

[1]  Martine,et al.  CD28, a marker associated with tumoral expansion in multiple myeloma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  B. Klein,et al.  Malignant plasma cell lines express a functional CD28 molecule , 1998, Leukemia.

[3]  N. Brünner,et al.  Effect of NCAM‐transfection on growth and invasion of a human cancer cell line , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[4]  G. Morgan,et al.  Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage , 1997, British journal of haematology.

[5]  W. O'Fallon,et al.  Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. , 1996, Blood.

[6]  B. Klein,et al.  A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1 , 1996, British journal of haematology.

[7]  M. Amiot,et al.  Myeloma Cells Upregulate Interleukin-6 Secretion in Osteoblastic Cells Through Cell-to-Cell Contact But Downregulate Osteocalcin , 1995 .

[8]  R. Bataille,et al.  Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. , 1995, Cancer research.

[9]  G. Ahmann,et al.  Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity? , 1995, British journal of haematology.

[10]  R. Bataille,et al.  Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. , 1994, Blood.

[11]  E. Bock,et al.  Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Sonneveld,et al.  Analysis of multidrug‐resistance (MDR‐1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma , 1993, British journal of haematology.

[13]  H. F. Barker,et al.  Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cells , 1992, British journal of haematology.

[14]  P. Lacor,et al.  Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells , 1991, British journal of haematology.

[15]  F. Walsh,et al.  Morphoregulatory activities of NCAM and N-cadherin can be accounted for by G protein-dependent activation of L- and N-type neuronal Ca2+ channels , 1991, Cell.

[16]  J. Drach,et al.  Expression of the neural cell adhesion molecule (CD56) by human myeloma cells , 1991, Clinical and experimental immunology.

[17]  T. Grogan,et al.  Plasma cells in multiple myeloma express a natural killer cell- associated antigen: CD56 (NKH-1; Leu-19) , 1990 .

[18]  P. Linsley,et al.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Gale,et al.  Plasma cell leukemia. , 1987, Seminars in hematology.

[20]  R. Kyle,et al.  Plasma cell leukemia. Report on 17 cases. , 1974, Archives of internal medicine.

[21]  B. Camp,et al.  Differential gene expression of the neural cell adhesion molecule (N-CAM) in a panel of multiple myeloma cell lines , 1998, Leukemia.

[22]  F. Walsh,et al.  Neural cell adhesion molecules of the immunoglobulin superfamily: role in axon growth and guidance. , 1997, Annual review of cell and developmental biology.

[23]  M. Amiot,et al.  Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. , 1995, Blood.

[24]  原田 浩徳.  Phenotypic difference of normal plasma cells from mature myeloma cells , 1993 .

[25]  T. Grogan,et al.  Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). , 1990, Blood.

[26]  M. Boccadoro,et al.  Reactive plasmacytosis. Case report and review of the literature. , 1985, Acta haematologica.

[27]  F. Leibetseder,et al.  [Plasma cell leukemia]. , 1973, Blut.